Compounds researched for longevity, neuroprotection, skin health, and general wellness applications.
Sort by
Position
Name: A to Z
Name: Z to A
Price: Low to High
Price: High to Low
Created on
Display
3
6
9
per page
Cyclic nonapeptide hormone with characteristic Cys1-Cys6 disulfide bridge, synthesized by Nobel laureate Vincent du Vigneaud (1954) OXTR agonist activating Gq/11-PLC-IP3/DAG cascade; modulates social cognition, stress axis, metabolism, and cardiovascular function Validated in ~25,000 publications spanning social neuroscience, reproductive physiology, psychiatry, metabolic medicine, and cardiology
Cyclic heptapeptide analog of alpha-MSH with 100-1000x greater potency at melanocortin receptors Pan-agonist of MC1R, MC3R, MC4R, MC5R with extended half-life (~33 hours vs. minutes for native alpha-MSH) Validated in 400+ publications across pigmentation, energy homeostasis, sexual function, neuroprotection, and cardiovascular research
SNAP-8 (Acetyl Octapeptide-3) is an 8-amino acid biomimetic peptide (Ac-EEMQRRAD-NH2) that competitively inhibits SNAP-25 incorporation into the SNARE complex, achieving ~43% inhibition of glutamate release. Developed as a topical alternative to botulinum toxin, it provides muscle relaxation (not paralysis) with reversible, dose-dependent modulation of neurotransmitter release.
Essential Cobalt-Containing Vitamin: Cyanocobalamin (C₆₃H₈₈CoN₁₄O₁₄P), 1000 mcg/mL injectable solutionMethylation Pathway Cofactor: Critical for methionine synthase and methylmalonyl-CoA mutase enzymatic reactionsNeurological Research Tool: Supports studies in myelin synthesis, DNA methylation, and neuroprotection
FDA-Approved Melanocortin Agonist: Cyclic heptapeptide MC3R/MC4R agonist, approved June 2019 (Vyleesi) for premenopausal HSDD, 100+ publications, first melanocortin therapeutic for sexual functionCNS Mechanism: Crosses blood-brain barrier, activates hypothalamic MC4R in mPOA triggering dopamine release, melanocortin-dopamine integration, mesolimbic reward pathway modulationClinical Development: 43 completed trials with 3,500+ subjects, Phase 3 RECONNECT (n=1,267) showed +0.35 desire improvement, 58% vs 36% responder rates, well-characterized safety profile
Lipo-C (10ml)
Profile: grade lipotropic complex containing L-Carnitine, L-Arginine, methionine, inositol, choline, and B-vitamins for laboratory studiesApplications: Mitochondrial β-oxidation and fatty acid transport mechanism studies via carnitine palmitoyltransferase shuttle systemQuality: >=95% Purity (HPLC Verified)
